JPS61152260A - Food containing vanilylamine - Google Patents

Food containing vanilylamine

Info

Publication number
JPS61152260A
JPS61152260A JP59281691A JP28169184A JPS61152260A JP S61152260 A JPS61152260 A JP S61152260A JP 59281691 A JP59281691 A JP 59281691A JP 28169184 A JP28169184 A JP 28169184A JP S61152260 A JPS61152260 A JP S61152260A
Authority
JP
Japan
Prior art keywords
diet
vanillylamine
fat
food
acid amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59281691A
Other languages
Japanese (ja)
Inventor
Kazuo Iwai
和夫 岩井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP59281691A priority Critical patent/JPS61152260A/en
Priority to DE19853520761 priority patent/DE3520761A1/en
Priority to US06/834,102 priority patent/US4680313A/en
Publication of JPS61152260A publication Critical patent/JPS61152260A/en
Priority to US07/002,942 priority patent/US4789687A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE:To provide the titled food such as butter, etc., containing vanilylamine or acid amide of vanilylamine, effective to prevent the increase or to decrease the fat of body, and to keep or decrease the body weight, and useful as a remedy for obesity. CONSTITUTION:The objective food can be prepared by compounding a food with vanilylamine, or vanilylamine acid amide free from unsaturated bond, or vanilylamine acid amide containing unsaturated bond and having <=8 or >=12 carbon number (e.g. the compound of formula I). The acid amide free from unsaturated bond is preferably <=8C compound, e.g. the compound of formula II, etc. The food to be treated is a food free from oil or fat, meat tenderizer, drink, etc.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、バニリルアミン又はバニリルアミンの酸アミ
ド(以下バニリルアミン類と総称する)の添加により、
体脂肪のjta加防止乃至は減少に有効な食品に関する
Detailed Description of the Invention [Industrial Application Field] The present invention provides the following advantages:
The present invention relates to foods that are effective in preventing or reducing body fat.

[発明が解決しようとする問題点] 総摂取カロリーの過剰、体脂肪の蓄積による肥満等に帰
因する各種の成人病をはじめとして、体脂肪の蓄積は、
脂肪、炭水化物等の摂取が比較的自由で、かつ、そガ代
謝を十分に行わしめ得ない体質又は環境゛におかれた′
人々に重大な健康上の危機をもたらし、もはや、ダイエ
ツト乃至は食事療法は、肥満症の患者等はもとより、単
なる体重コントロールを希望する健康な人々においても
不可欠の課題となりつつある。
[Problems to be solved by the invention] Accumulation of body fat causes various adult diseases such as obesity caused by excessive total caloric intake and accumulation of body fat.
Those who have a relatively free intake of fats, carbohydrates, etc., and who have a constitution or environment that does not allow them to metabolize them sufficiently.
BACKGROUND ART BACKGROUND OF THE INVENTION This poses a serious health crisis to people, and diet or diet therapy is becoming an indispensable issue not only for obese patients but also for healthy people who simply wish to control their weight.

このようなダイエツト乃至は食事療法は後述する各秒の
方法におけるように、しばしば、油脂や炭水化物の摂取
量を制限したり、或いは、全体の食事量、摂取エネルギ
ーを制限する等で過酷で忍耐を必要とされることから、
途中で放棄する等、必ずしも成功には繋がらない。
Such diets or dietary therapies are often harsh and require patience, such as by restricting the intake of fats and carbohydrates, or by restricting the total amount of food and energy intake, as in the methods described below. Because it is needed,
It does not necessarily lead to success, such as abandoning it midway through.

従って、油脂、炭水化物等の食事の種類、量等を制限さ
れることなく、体脂肪の減少をもたらす方法が医薬品等
によらず、食品において可能であれば食事療法等に多大
な福音をもたらす。従って、医療上の理由はもとより、
単に体重増加を望まない人々においても、そのJ:うな
体脂肪の増加を防止し乃至は減少をもたらし、結果的に
体重の維持乃至は減少に導く食品の実現が希求されてい
る。
Therefore, if there is a way to reduce body fat without restricting the type and amount of fats, carbohydrates, etc. in the diet, without relying on pharmaceuticals, etc., it would bring great news to dietary therapy. Therefore, in addition to medical reasons,
Even for people who simply do not want to gain weight, there is a desire for food products that prevent or reduce body fat and, as a result, maintain or reduce body weight.

[従来技術] 体脂肪の蓄積を防止し、或いは、体脂肪の減少を図る方
法は、(1)高甘味度の月味料の使用やコンニャク等の
代謝されない食物を摂取する、更には食欲抑制剤を服用
する等に代表されるようにカロリー摂取m自体を減少さ
せる方法と、(2)例えば、体操やマツサージ等の物理
的方法や体脂肪代謝促進作用を有する食物乃至は医薬の
摂取等に代表される体脂肪の代謝を促進する方法とに大
別される。
[Prior Art] Methods for preventing body fat accumulation or reducing body fat include (1) using highly sweetened moon flavoring agents, ingesting non-metabolized foods such as konnyaku, and suppressing appetite; (2) physical methods such as gymnastics and pine surges, and intake of foods or medicines that promote body fat metabolism. It can be broadly divided into methods that promote the metabolism of body fat.

後者、即ち、体脂肪の代謝を促進する方法において、医
薬的療法としては、例えば、ニコチン酸d1−α−トコ
フェロール、オキリンドロロン、クロフィブラート等の
脂質代謝改善剤をはじめ、各種のものが存在するが、食
品において、かかる機能を有する例は、わずかに、特開
昭57−122765にお【ノるウリ利植物のサポニン
成分濃縮物を必須成分とする健康食品等が知られている
にすぎない。
In the latter method, that is, a method of promoting body fat metabolism, there are various pharmaceutical treatments, including lipid metabolism improving agents such as d1-α-tocopherol nicotinate, ochirindrolone, and clofibrate. However, there are only a few known examples of foods that have such functions, such as those described in Japanese Patent Application Laid-Open No. 122765/1983 [Health foods containing a concentrated saponin component of cucurbit cucurbits as an essential ingredient]. do not have.

一方、バニリルアミン類の有用性に関する知見は、炭素
数10で、代表的辛味物質であるカブサイシンの抗酸化
性が知られている〈特公昭51−40876、油化学第
29巻第6号(1980)31頁〜34頁)。しかしな
がら、抗酸化性以外の具体的有用性に関する知見はほと
んど存在しない。
On the other hand, the knowledge regarding the usefulness of vanillylamines is that they have 10 carbon atoms and are known to have antioxidant properties for kabsaicin, which is a representative pungent substance (Japanese Patent Publication No. 51-40876, Yukagaku Vol. 29, No. 6 (1980)). (pp. 31-34). However, there is almost no knowledge regarding specific usefulness other than antioxidant properties.

[発明の目的] 本発明の目的は、肥満症、高脂血症等の患者、更には体
重の増加を望まない人々等に、体脂肪を増加防止し、乃
至は減少させ体重の維持乃至は減少をもたらす食品を提
供することにある。
[Objective of the Invention] The object of the present invention is to prevent or reduce body fat and maintain or maintain body weight in patients with obesity, hyperlipidemia, etc., as well as in people who do not wish to gain weight. The aim is to provide food that reduces the

[問題点を解決するための手段] 本発明は、油脂を含まない食品に、バニリルアミン、又
は、バニリルアミンの不飽和結合を含まない酸アミド若
しくはバニリルアミンの不飽和結合を含む炭素数8以下
又は12・以上の酸アミド(バニリルアミドと略記する
)を添加する。このような不飽和結合を含まない酸アミ
ドの代表例には、・下記(1)式で表されるジヒドロカ
ブサイシン、下記(2)式で表・されるノルジヒドロカ
ブサイシン、=5− 下記(3)式で表されるホモジヒドロ力ブザイシンが挙
げられる。この他にも、ノナナミド(式(4) (5)
(6))、プロピオナミド(式(7))、オクタナミド
(式(8)(9))、デカナミド(式(10)  (1
1) 、) 、ウンデセナミド(式(12) ) 、プ
ロパナミド(式(13) ’) 、アセタミド(式(1
4))、オクタデカナミド(式(15) ) 、ヘキサ
ナミド(式(16))、ヘプタナミド(式(17) )
 、ドデカナミド(式(18) ) 、テトラデカナミ
ド(式(19))、ヘキサデカナミド(式(20)’ 
) 、ドコサナミド(式(21) )等が知られている
が、本発明では、天然、合成のいずれかを問わず、バニ
リルアミンの不飽和結合を含まない酸アミドであれば、
使用可能である。
[Means for Solving the Problems] The present invention provides foods that do not contain oil or fat with vanillylamine, or an acid amide that does not contain an unsaturated bond of vanillylamine, or a carbon number of 8 or less or 12 carbon atoms that contains an unsaturated bond of vanillylamine. The above acid amide (abbreviated as vanillyl amide) is added. Typical examples of such acid amides that do not contain unsaturated bonds include dihydrocabsaicin represented by the following formula (1), nordihydrocabsaicin represented by the following formula (2), =5- Examples include homodihydrobutycin represented by formula (3). In addition, nonanamide (formula (4) (5)
(6)), propionamide (formula (7)), octanamide (formula (8), (9)), decanamide (formula (10) (1
1), ), undecenamide (formula (12)), propanamide (formula (13)'), acetamide (formula (1)
4)), octadecanamide (formula (15)), hexanamide (formula (16)), heptanamide (formula (17))
, dodecanamide (formula (18)), tetradecanamide (formula (19)), hexadecanamide (formula (20)')
), docosanamide (formula (21)), etc., but in the present invention, any acid amide, whether natural or synthetic, that does not contain an unsaturated bond of vanillylamine,
Available for use.

式(1) 式(2) 式(3) 式(4) 式(5) 式(6) 式(7) 式(8) 式(9) 式(10) 式(11) 式(12) 式(13) 式(14) 式(15) 式(16) 9一 式(17) 式(18) 式(19) 式(20) 式(21) また、不飽和結合を含む炭素数8以下又は12以上のバ
ニリルアミドの代表例には、ビスホモカブサイシン(C
2[I H3s NO3)、トリスホモカブ”tイシン
(C2t 1−133 NO3) 17)他、下記(2
2)式で表される4−へブタナミド、下記(23)式で
表されるリノールアミド、下記(24)式で表される9
−オクタデセナミド等が挙げられるが、本発明では、天
然、合成のいずれかを問わず、バニリルアミンの不飽飽
和結合を含む酸アミドであれば、使用可能である。
Equation (1) Equation (2) Equation (3) Equation (4) Equation (5) Equation (6) Equation (7) Equation (8) Equation (9) Equation (10) Equation (11) Equation (12) Equation ( 13) Formula (14) Formula (15) Formula (16) 9 set (17) Formula (18) Formula (19) Formula (20) Formula (21) In addition, a carbon number of 8 or less or 12 or more containing an unsaturated bond Representative examples of vanillylamide include bishomocabsaicin (C
2 [I H3s NO3), Tris Homokabu”t Isine (C2t 1-133 NO3) 17), and the following (2
2) 4-hebutanamide represented by the formula (23) below, linolamide represented by the following formula (24), 9 represented by the following formula (24)
-Octadecenamide, etc. However, in the present invention, any acid amide containing an unsaturated bond of vanillylamine can be used, regardless of whether it is natural or synthetic.

式(22) 式(23) 式(24) 上記バニリルアミン類は1種単独でも、2種以上の組合
せでもよい。また、例えば、トウガラシ等のバニリルア
ミン類を含有する植物をそのまま又はこれらの植物から
上記バニリルアミン類含有抽出物として分取したもの等
を使用してもよい。
Formula (22) Formula (23) Formula (24) The above vanillylamines may be used alone or in combination of two or more. Furthermore, for example, vanillylamine-containing plants such as chili pepper may be used as they are, or extracts prepared from these plants as the vanillylamine-containing extract may be used.

バニリルアミン類の含有量は高くなる程、本発明の効果
は大きいが、バニリルアミドの種類によっては添加量が
制約される場合がある。特に、09〜C3tのバニリル
アミドは一般には強い辛味を有し、組合せる食品成分の
種類、組成比等によっては、官能上好ましくない場合も
生じる。従って、C9〜11のバニリルアミドを用いる
場合、単独で高濃度の使用を避け、C8以下若しくは0
12以上のバニリルアミド又はバニリルアミンと組合せ
て使用することが望ましいが、これらCa〜!1のバニ
リルアミドのみを使用する場合は例えば、酸味料、甘味
料その伯の辛味を緩和する成分を併用したり、カプセル
化等により、口腔内で強い辛味を発現しないような添加
方法を選択する、或いは、喫食時、稀釈により辛味を緩
和することが望ましく、また、喫食時、稀釈せずそのま
ま飲食される食品ではC9〜11のバニリルアミドの濃
度として1%より高濃度での使用は、一般的には、辛味
が強くなり過ぎる場合が多いため1%より低濃度での使
用が好ましい。しかしながら、1%より高濃度でも、上
記辛味緩和成分の併用、カプセル化等によっては、官能
上許容し得る範囲で実用に供し得る非稀釈タイプの食品
を提供可能である。逆に、Cg〜C1lのバニリルアミ
ドの含有量の下限については特に限定されないが、1 
my%より低濃度になると、はとんど本発明の効果は期
待できなくなる。従って、09〜11のバニリルアミド
の至適含有量は11ftg%〜1%である。尚、バニリ
ルアミン又は08以下若しくはC12以上のバニリルア
ミドのみの使用については、高濃度で官能上問題を生じ
ることは少ない。
The higher the content of vanillylamines, the greater the effect of the present invention, but the amount added may be restricted depending on the type of vanillylamide. In particular, 09-C3t vanillylamide generally has a strong pungent taste, and depending on the type of food ingredients to be combined, composition ratio, etc., it may be undesirable from a sensory point of view. Therefore, when using C9-11 vanillylamide, avoid using it alone in high concentration, and avoid using C8 or less or 0.
It is desirable to use it in combination with 12 or more vanillylamides or vanillylamines, but these Ca~! When using only vanillylamide (1), select an addition method that does not produce a strong pungent taste in the oral cavity, such as by using an acidulant, a sweetener, or an ingredient that alleviates the pungent taste, or by encapsulating it. Alternatively, when eating, it is desirable to reduce the spiciness by diluting, and in foods that are eaten as is without dilution, it is generally recommended not to use C9-11 vanillylamide at a concentration higher than 1%. It is preferable to use it at a concentration lower than 1% because the spiciness often becomes too strong. However, even if the concentration is higher than 1%, it is possible to provide a non-diluted type of food that can be used for practical purposes within an organoleptically acceptable range by using the above-mentioned spiciness-reducing ingredients in combination, encapsulation, etc. Conversely, the lower limit of the content of vanillylamide from Cg to C1l is not particularly limited, but is 1
When the concentration is lower than my%, the effects of the present invention can hardly be expected. Therefore, the optimum content of vanillylamide in Nos. 09 to 11 is 11 ftg% to 1%. It should be noted that the use of only vanillylamine or vanillylamide of C12 or lower or C12 or higher is unlikely to cause any sensory problems at high concentrations.

13一 本発明の対象となる食品としては、油脂及び油脂を含有
する食品(バター、ラード、ヘットその他の動物脂、魚
油等の動物油、菜種油、大豆油、綿実油、とうもろこし
油等の植物油、植物硬化油、植物脂等の油脂又はフライ
、ソース、マヨネーズ、ドレッシング、ペースト、ソー
セージ、ハム、脱脂していない魚、肉類、その他のあら
ゆる油脂含有食品)のみならず、油脂を含有していない
食品(油脂を含まない調味料、ミートテンダライザー、
飲料等、少くとも保存乃至は流通期間中に油脂と共存し
ない食品であり、例えば飲食される際に油脂とともに摂
取されるような食品も含まれる。)が含まれ、いずれの
場合も、体脂肪の増加を防止し、乃至は減少させ、体重
の維持乃至は減少に導くことが可能である。
131 Foods covered by the present invention include fats and oils and foods containing fats and oils (butter, lard, animal fats such as fat, animal oils such as fish oil, vegetable oils such as rapeseed oil, soybean oil, cottonseed oil, corn oil, etc.), and hardened vegetable oils. Not only foods that contain fats such as oils, vegetable fats, or fried foods, sauces, mayonnaise, dressings, pastes, sausages, hams, non-skimmed fish, meat, and all other fats and oils, but also foods that do not contain fats and oils (oils and fats). Contains no seasonings, meat tenderizers,
It refers to foods such as beverages that do not coexist with fats and oils at least during storage or distribution, and also includes foods that are ingested together with fats and oils when eating or drinking. ), and in either case, it is possible to prevent or reduce the increase in body fat and lead to the maintenance or reduction of body weight.

バニリルアミン類の添加方法は、特に限定されないが、
特に、09〜11のバニリルアミドを高濃度(特に喫食
時濃度で1%以上)で含有せしめる場合には、予め、カ
プセル化(口腔内では分゛解されず、消化器官内で分解
されるカプセル化剤に=14− より、カブ廿ル化することが好ましい)したものを添加
する等の方法によることが望ましい。
The method of adding vanillylamines is not particularly limited, but
In particular, when containing vanillylamides 09 to 11 at high concentrations (particularly 1% or more in ingested concentration), it is necessary to encapsulate them in advance (capsules that are not decomposed in the oral cavity but decomposed in the digestive tract). It is preferable to use a method such as adding a compound (preferably converted to a carboxylic acid) to the agent.

実施例1 アレヂルバニリルアミド、ジヒドロカプ−リーイシン、
ステアロイルバニリルアミド又はバニリルアミン含有ダ
イエツト食を第1表の配合により調製した。
Example 1 Aledylvanillylamide, dihydrocapryicin,
A diet food containing stearoyl vanillylamide or vanillylamine was prepared according to the formulation shown in Table 1.

ウィスター(Wister)系雄ラット(初体重170
〜180g)に上記で調製した高脂肪食A〜E(脂肪エ
ネルギー比60%)又は対照どしての市販ダイエツト(
オリエンタル酵母社製、オリエンタルM「ダイエツト)
を10日間与えた後、血中トリグリセリド値及び腎周囲
脂肪組織重量を測定し、更に、肝での脂肪酸合成に関与
するグルコース−6−リン酸脱水素酵素活性及び腎周囲
脂肪組織のリポプロティンリパーゼ活性を測定したとこ
ろ、バニリルアミン類を含まないダイエツトを組合せた
高脂肪食E摂取群に比べ、バニリルアミン類を含有する
ダイエツトを併用した高脂肪食A−D摂取群は、腎周囲
脂肪組織重量及び血中トリグリセリド値の有意な低下が
認められた。更に、肝での脂肪酸合成に関与するグルコ
ース−6−リン酸脱水素酵素活竹及び腎周囲l111織
のリボプロテぐ9 インリパーゼ活性の有意な増加が高脂肪食A摂取群で認
められた。これらの結果から、本発明のバニリルアミン
類含有ダイエツトは、高脂肪食摂取うッ1〜において、
脂質代謝を孔道するものど11f定される。
Wistar male rat (initial weight 170
~180g) and the high-fat diets A to E prepared above (fat energy ratio 60%) or a commercially available control diet (
Oriental M “Diet” manufactured by Oriental Yeast Co., Ltd.
After feeding for 10 days, blood triglyceride levels and perinephric adipose tissue weight were measured, and the activity of glucose-6-phosphate dehydrogenase, which is involved in fatty acid synthesis in the liver, and lipoprotein lipase in perinephric adipose tissue were measured. When the activity was measured, compared to the group consuming high-fat diet E in combination with a diet containing no vanillylamines, the group consuming high-fat diets A-D in combination with a diet containing vanillylamines had lower perinephric adipose tissue weight and blood pressure. A significant decrease in middle triglyceride levels was observed. Furthermore, a significant increase in activity of glucose-6-phosphate dehydrogenase active bamboo, which is involved in fatty acid synthesis in the liver, and riboprotein lipase activity in perirenal l111 tissue was observed in the high-fat diet A intake group. From these results, it is clear that the vanillylamine-containing diet of the present invention has the following benefits:
11f is defined as one that controls lipid metabolism.

実施例2 ビスホモカブサイシン、トリスホモカブサイシン、リノ
ールアミド又は4−へブタナミド含有ダイエツト食を第
2表の配合により調製した。
Example 2 Dietary foods containing bishomokabsaicin, trishomokabsaicin, linoleamide, or 4-hebutanamide were prepared according to the formulations shown in Table 2.

ウィスター(Wister )系雄ラット(初体重17
0〜180g>に上記で調製した高脂肪食A〜F(脂肪
エネルギー比60%)又は対照としての市販ダイエツト
(オリエンタル酵母社製、オリエンタルMFダイエツト
)を10日間与えた後、血中トリグリセリド値及び腎周
囲脂肪組織重量を測定し、更に、肝での脂肪酸合成に関
与するグルコース−6−リン酸脱水素酵素活性及び腎周
囲脂肪組織のリポプロティンリパーゼ活性を測定したと
ころ、バニリルアミン類を含まないダイエツトを組合せ
た高脂肪食E摂取群に比べ、バニリルアミドを含有する
ダイエツトを併用した高脂肪食A〜D摂取群は、腎周囲
脂肪組織重量及び血中トリグリセリド値の有意な低下が
認められた。更に、肝での脂肪酸合成に関与するグルコ
ース−6−リン酸脱水素酵素活性及び腎周囲組織のりボ
ブロテー−レ インリパーゼ活性の有意な増加が高脂肪食A摂取群で認
められた。これらの結果から、本発明のバニリルアミド
含有ダイエツトは、高脂肪食摂取ラットにおいて、脂質
代謝をへ進するものと推定される。
Wistar male rat (initial weight 17
After feeding high-fat foods A to F (fat energy ratio 60%) prepared above or a commercially available diet as a control (Oriental MF Diet, manufactured by Oriental Yeast Co., Ltd.) for 10 days, blood triglyceride levels and We measured the weight of perirenal adipose tissue, and also measured the activity of glucose-6-phosphate dehydrogenase, which is involved in fatty acid synthesis in the liver, and the lipoprotein lipase activity of perirenal adipose tissue. Compared to the group that consumed high-fat diet E in combination with diet containing vanillylamide, the groups that consumed high-fat diets A to D in combination with diet containing vanillylamide were found to have significantly lower perinephric adipose tissue weights and blood triglyceride levels. Furthermore, a significant increase in glucose-6-phosphate dehydrogenase activity involved in fatty acid synthesis in the liver and bobroterein lipase activity in perinephric tissues was observed in the high-fat diet A group. From these results, it is estimated that the vanillylamide-containing diet of the present invention promotes lipid metabolism in rats ingesting a high-fat diet.

実施例3 カゼイン10重量部、澱粉40重量部、蔗糖10重量部
、混合ミネラル2重儀部、混合ビタミン1重量部、セル
ロース1重量部及びジヒドロカブサイシン0.014重
量部を混合し、ダイエツトを調製した。
Example 3 10 parts by weight of casein, 40 parts by weight of starch, 10 parts by weight of sucrose, 2 parts by weight of mixed minerals, 1 part by weight of mixed vitamins, 1 part by weight of cellulose and 0.014 parts by weight of dihydrocabsaicin were mixed and the diet was started. Prepared.

このダイエツトをウィスター系雄うッ1〜(初体重17
0〜180g)15匹に、各々6.5!J/日の割合で
、ラード(3g/日)、大豆油(0,57/日)と共に
10日間与えた。
This diet is suitable for Wistar males (initial weight 17
0-180g) 6.5 each for 15 animals! It was fed for 10 days with lard (3 g/day) and soybean oil (0.57/day) at a rate of J/day.

対照として、ウィスター系雄ラット(初体重170〜1
8(1)15匹に対し、上記高脂肪食摂取群と摂取カロ
リー最において同一どなるように、市販ダイエツト(オ
リエンタル酵母社製、オリエンタルMFダイエツ1〜)
を10日間与えた。
As a control, Wistar male rats (initial weight 170-1
8 (1) 15 mice were given a commercially available diet (Oriental MF Diets 1~, manufactured by Oriental Yeast Co., Ltd.) so that the caloric intake was the same as that of the high-fat diet intake group.
was given for 10 days.

10日間経過後の体重増加量を測定した結果、本発明の
ジヒドロカブザイシン含有ダイエツ1〜を油脂と共に摂
取した群は、対照摂取群に比べ、先口り一摂取量は同一
にもかかわらず体重増加は約1/2にとどまった。
As a result of measuring the amount of weight gain after 10 days, the group that ingested the dihydrocabzaicin-containing diets 1 to 1 of the present invention together with fats and oils showed that the group that ingested the dihydrocabzaicin-containing diets 1 to 3 of the present invention had a lower body weight gain than the control group, despite the fact that the intake amount was the same. The weight gain was only about 1/2.

実施例4 実施例3のジヒドロカブサイシンをバニリルアミンに変
え、そのほかの条件を同一としてダイエツトの調製及び
ラットを用いた声験を行ったところ、バニリルアミン摂
取群の平均体重増加量は、対照摂取群に比べ約1/2に
とどまった。
Example 4 Dihydrocabsaicin in Example 3 was replaced with vanillylamine, and other conditions were kept the same, and a diet was prepared and a voice test was conducted using rats. It was only about 1/2 of that.

実施例5 実施例3のジヒドロカブサイシンをアセチルバニリルア
ミドに変え、そのほかの条件を同一として、ダイエツト
の調製及びラットを用いた実験を行なったところ、アセ
チルバニラルアミド摂取群の平均体重増加量は、対照摂
取群にくらべ約1/2にとどまった。
Example 5 When dihydrocabsaicin in Example 3 was replaced with acetylvanillylamide and other conditions were the same, a diet was prepared and an experiment was conducted using rats. was only about 1/2 that of the control group.

実施例6 実施例3のジヒドロカブサイシンをステアロイルバニリ
ルアミドに変え、そのほかの条件を同一として、ダイエ
ツトの調製及びラットを用いた実験を行なったところ、
ステアロイルバニラルアミド摂取群の平均体重増加量は
、対照摂取群にくらべ約1/2にとどまった。
Example 6 Dihydrocabsaicin in Example 3 was replaced with stearoylvanillylamide, and other conditions were kept the same, and a diet was prepared and an experiment was conducted using rats.
The average weight gain of the group taking stearoylvanilamide was only about 1/2 that of the group taking the control.

実施例7 調  味  利 食   塩               12.5部
砂   糖              80.7部ジ
ヒドロカブ゛号イシン*   6.8部*常法によりゼ
ラチンでハードカプセル化したもの 上記組成の調味料をサラダ油、卵黄及び食酢水とともに
乳化し、ジヒドロカブサイシン含量が1%のドレッシン
グを調製した。
Example 7 Seasoning Flavor Food Salt 12.5 parts Sugar 80.7 parts Dihydrocarb No. Isin* 6.8 parts *Hard encapsulated with gelatin by conventional method Seasoning with the above composition was added with salad oil, egg yolk, and vinegar water. A dressing with a dihydrocabsaicin content of 1% was prepared by emulsification.

このドレッシングをウィスター系雄ラットに対し、13
/日の割合で別途調製した高脂肪食(1日当りカゼイン
1g、澱粉4g、蔗糖1g、ラード2.5g、混合ミネ
ラル0.2g、混合ビタミン0.17、セルロース0.
2g)と交互に10日間与えた。対照として、ウィスタ
ー系雄ラットに対し、上記高脂肪食摂取群と摂取カロリ
ーにおいて同一となるように市販ダイエツトを10日間
は対照に比べ平均体重増加量が約1/2にとどまった。
Apply this dressing to Wistar male rats for 13 days.
A high-fat diet prepared separately at a rate of 1.5 g per day (1 g of casein, 4 g of starch, 1 g of sucrose, 2.5 g of lard, 0.2 g of mixed minerals, 0.17 g of mixed vitamins, and 0.0 g of cellulose per day).
2g) for 10 days. As a control, when male Wistar rats were fed a commercially available diet for 10 days so as to have the same calorie intake as the high-fat diet group, the average weight gain was only about 1/2 compared to the control.

実施例8 焼き肉用のたれ 濃口しょうゆ       35.0ml濃口みりん 
       10.Od本みりん         
 3.Od赤ワイン          3.0成ソル
ビツト        10.0!7砂   糖   
            13.09グルタミン酸ナト
リウム   1.5g[アミリッチCRJ      
 O,5g[アジエキス13−、I J     1.
 (150%乳酸         0.3gおろし生
にんに(4,,59 おろし生しようが      1.5gオニオンパウダ
ー      2.0gジヒドロカブサイシン    
2.、Og白こしよう         0.05g白
ごま           0.5g水       
              19. 11dl上記配
合に従い原料を混合・加熱し、焼き肉用のだれを調製し
た。
Example 8 Dark soy sauce for grilled meat 35.0ml Dark mirin
10. Od Hon Mirin
3. Od red wine 3.0 sorbitol 10.0!7 sugar
13.09 Sodium glutamate 1.5g [Amirich CRJ
O, 5g [Aji Extract 13-, I J 1.
(150% lactic acid 0.3g grated raw garlic (4,,59 grated raw ginger 1.5g onion powder 2.0g dihydrocabsaicin
2. , Og white pepper 0.05g white sesame 0.5g water
19. 11 dl The raw materials were mixed and heated according to the above formulation to prepare sauce for grilled meat.

牛肉(ばら肉、脂肪含有率41.0%)にこの焼き肉の
だれを塗布又は牛肉をこのたれにつ【ノ込み処理した。
Beef (belly meat, fat content 41.0%) was coated with this grilled meat sauce, or beef was coated with this sauce.

この牛肉をウィスター糸紐ラットに10g/日の割合で
市販のダイエツトと併用して10日間与えた。
This beef was fed to Wistar string rats at a rate of 10 g/day for 10 days in combination with a commercially available diet.

対照として、上記牛肉併用食摂取群と摂取カロリー量に
おいて同一となるように市販ダイエツトのみをウィスタ
ー糸紐ラットに対し10日間与えた。
As a control, Wistar cord rats were fed only a commercially available diet for 10 days so that the caloric intake was the same as that of the beef-containing diet group.

10日間経過後の体重増加量を測定したところ、カロリ
ー摂取量は同一にもかかわらず、本発明の背サイシン含
有牛肉摂取群の平均体重増加量は、対照に比べ1/2に
とどまった。
When the amount of weight gain was measured after 10 days, the average amount of weight gain in the beef consuming group containing dorsal cysin of the present invention was only 1/2 that of the control, even though the caloric intake was the same.

実施例9 バ  タ  −              99重量
部アセ′チルバニリルアミド   1重量部バターにア
セヂルバニリルアミドを練込み、アセチルバニリルアミ
ド1%含有バターを調製した。
Example 9 Butter - 99 parts by weight Acetyl vanillylamide 1 part by weight Butter was kneaded with acetyl vanillylamide to prepare butter containing 1% acetyl vanillylamide.

このバターを官能評価したところ、辛味は感ぜられず、
市販のバターに比べ、味、風味共に変わらないとの結果
を得た。
When this butter was sensory evaluated, no spiciness was detected.
The results showed that there was no difference in taste and flavor compared to commercially available butter.

得られたアセチルバニリルアミド含有バターをウィスタ
ー糸紐ラット(初体重170〜180g)15匹に、各
々3.5g/日の割合で、別途調製したダイエツト(1
日当りカゼイン1g、澱粉49、蔗糖1g、ラードク、
gg、混合ミネラル0.29、混合ビタミン0.1g、
セルロース0.2g)ど共に10日間与えた。
The obtained acetylvanillylamide-containing butter was fed to 15 Wistar string rats (initial weight 170-180 g) at a rate of 3.5 g/day for each separately prepared diet (1
Daily casein 1g, starch 49, sucrose 1g, lard,
gg, mixed minerals 0.29, mixed vitamins 0.1g,
0.2 g of cellulose) was given to the mice for 10 days.

対照として、ウィスター糸紐ラット(初体重170〜1
80g)15匹に対し、上記バター、ダイエツト併用摂
取群と摂取カロリー量において同一となるように、市販
ダイエツト(オリエンタル酵母社製、オリエンタルMF
ダイエツト)を10日間与えた。
As a control, Wistar string rats (initial weight 170-1
A commercially available diet (manufactured by Oriental Yeast Co., Ltd., Oriental MF
diet) for 10 days.

10日間経過後の体重増加量を測定した結果、本発明の
アセチルバニリルアミド含有バターをダイエツトと共に
摂取した群は、対照摂取群に比べ、カロリー摂取量は同
一にもかかわらず体重増加は約1/2にとどまった。
As a result of measuring the amount of weight gain after 10 days, the group that ingested the acetylvanillylamide-containing butter of the present invention with their diet showed a weight gain of about 1% compared to the control group, despite the same calorie intake. It stayed at /2.

実施例10 カゼイン10重量部、澱粉40重量部、蔗糖10重量部
、混合ミネラル2重量部、混合ビタミン1重量部、セル
ロース1重量部及びリノールアミドO,’019重1部
を混合し、ダイエツトを調製した。
Example 10 10 parts by weight of casein, 40 parts by weight of starch, 10 parts by weight of sucrose, 2 parts by weight of mixed minerals, 1 part by weight of mixed vitamins, 1 part by weight of cellulose, and 1 part by weight of linoleamide O,'019 were mixed and the diet was started. Prepared.

このダイエツトをウィスター糸紐ラット(初体重170
〜18’Og)15匹に、各々6.5g”/日の割合で
、ラード(3g/日)、大豆油(0,5g/日)と共に
10日間与えた。   □対照として、ウィスター糸紐
ラット(初体重170〜180g)15匹に対し、上記
高脂肪食摂取群と摂取カロリー量において同一となる゛
ように、市販ダイエツト(オリエンタル酵母社製、オー
リエンタルMF、ダイエツト)を10日間与えた。
This diet was applied to Wistar string rats (initial weight 170
~18'Og) were fed for 10 days with lard (3g/day) and soybean oil (0.5g/day) at a rate of 6.5g''/day each. □As a control, Wistar string rats Fifteen mice (initial weight 170-180 g) were fed a commercially available diet (Oriental MF, Diet, manufactured by Oriental Yeast Co., Ltd.) for 10 days so that the caloric intake was the same as that of the high-fat diet intake group.

10日間経過後の体重増加・錦を測定した結果、本発明
のリノールアミド含有ダイエツトを油脂と共に摂取した
群は、対照摂取群に比べ、カロリー摂取量は同一にもか
かわらず体重増加は約1/2にとどまった。
As a result of measuring weight gain and weight after 10 days, the group that ingested the linoleamide-containing diet of the present invention along with fats and oils had a weight gain of about 1/2 compared to the control group, despite having the same caloric intake. It stayed at 2.

実施例11 実施例10のリノールアミドを4−へブタナミドに変え
、そのほかの条件を同一としてダイエツトの調製及びラ
ットを用いた実験を行なったところ、バニリルアミド摂
取群の平均体重増加量は、対照摂取群に比べ約1/2に
とどまった。
Example 11 When linoleamide in Example 10 was replaced with 4-hebutanamide and other conditions were the same, a diet was prepared and an experiment was conducted using rats. The average weight gain of the vanillylamide intake group was lower than that of the control intake group. It was only about 1/2 compared to the previous year.

実施例12 調  味  料 食   塩              12.5部砂
   糖              80.7部ジヒ
ドロカブサイシン*   9.2部*常法によりゼラチ
ンでハードカプセル化したもの 上記組成の調味料をサラダ油、卵゛黄及び食酢水ととも
に乳化し、□リノールアミド含量が1%のドレッシング
を調製した。
Example 12 Seasoning Food Salt 12.5 parts Sugar 80.7 parts Dihydrocabsaicin* 9.2 parts *Hard encapsulated with gelatin by conventional method Seasoning with the above composition was mixed with salad oil, egg yolk and vinegar water. A dressing with a linoleamide content of 1% was prepared by emulsifying the mixture with the above ingredients.

9のドレッシングをウィスタニ系雄ラットに対し′、1
g/日の割合で別捺調製した高脂肪i(1日当りノJゼ
イン1g、澱粉4g、蔗糖1q1ラード2.5SJ、混
合ミネラル0.2q、混合ビタミン0.1g、セルロー
ス0.27)と交互に10日間与えた。対照として、ウ
ィスター糸紐ラットに対し、上記高脂肪食摂取群と摂取
カロリーにおいて同一となるように市販ダイエツトを1
0日間与えた。10日間経過後の体重増加量を測定した
ところ、本発明のリノールアミド−高脂肪食摂取群は対
照に比べ平均体重増加量が約1/2にとどまった。
Dressings of 9 and 1 were applied to Wistani male rats.
Alternating with high fat i prepared separately at the rate of g/day (1 g of Zein, 4 g of starch, 1 q of sucrose, 2.5 SJ of lard, 0.2 q of mixed minerals, 0.1 g of mixed vitamins, 0.27 g of cellulose per day) was given for 10 days. As a control, Wistar cord rats were given one portion of a commercially available diet so that the caloric intake was the same as that of the high-fat diet group.
It was given for 0 days. When the weight gain was measured after 10 days, the average weight gain in the linoleamide-high fat diet group of the present invention was only about 1/2 compared to the control.

実施例13 焼き肉用のたれ 濃口しょうゆ       35.0d澗口みりん  
      10.Od本みりん          
3.0ml赤ワイン          3.Odソル
ビット        ”+o、oy砂   糖   
            13.0!?グルタミン酸す
1〜リウム   1.5g[アミリッヂCRJ    
  0.5g「アジエキスB−IJ     1.0g
50%乳酸         0.33おろし生にんに
<       4.5yおろし生しょうが     
 1.5gオーニオンパウダー      2.0gリ
ノールアミド       2.7g白こしょう   
      O,O!M白ごま           
0.59水                    
 19.1mff1上記配合に従い原料を混合・加熱し
、焼き肉用のだれを調製した。
Example 13 Dark soy sauce for grilled meat 35.0d Akakuchi mirin
10. Od Hon Mirin
3.0ml red wine 3. Od sorbitol ”+o, oy sugar
13.0! ? Glutamate 1-1.5g [Amiridge CRJ
0.5g "Aji Extract B-IJ 1.0g
50% lactic acid 0.33 grated raw garlic < 4.5y grated raw ginger
1.5g onion powder 2.0g linoleamide 2.7g white pepper
O, O! M white sesame
0.59 water
19.1mff1 Raw materials were mixed and heated according to the above formulation to prepare sauce for grilled meat.

牛肉(ばら肉、脂肪含有率41.0%)にこの焼き肉の
だれを塗布又は牛肉をこのたれにつけ込み処理した。こ
の牛肉をウィスター糸紐ラットに10g/日の割合で市
販のダイエツトと(Jl用して10日間与えた。
Beef (belly meat, fat content 41.0%) was coated with this grilled meat sauce, or beef was soaked in this sauce and treated. This beef was fed to Wistar string rats at a rate of 10 g/day for 10 days as a commercially available diet (Jl).

対照として、上記牛肉併用食摂取群と摂取カロリー量に
おいて同一となるように市販ダイエラ1〜のみをウィス
ター糸紐ラットに対し10日間与えた。
As a control, Wistar cord rats were given only commercially available Daiera 1 to 1 for 10 days so that the caloric intake was the same as that of the group that consumed the beef combination diet.

10日間経過後の体重増加量を測定したところ、カロリ
ー摂取量は同一にもかかわらず、本発明のリノールアミ
ド含有牛肉摂取群の平均体重増加量は、対照に比べ1/
2にとどまった。
When measuring the amount of weight gain after 10 days, the average amount of weight gain in the linoleamide-containing beef intake group of the present invention was 1/1 that of the control, despite the same caloric intake.
It stayed at 2.

Claims (7)

【特許請求の範囲】[Claims] (1)バニリルアミン又はバニリルアミンの不飽和結合
を含まない酸アミド又はバニリルアミンの不飽和結合を
含む炭素数C_8以下又はC_1_2以上の酸アミドを
含有することを特徴とするバニリルアミン類含有食品。
(1) A vanillylamine-containing food product characterized by containing vanillylamine, an acid amide containing no unsaturated bond of vanillylamine, or an acid amide containing an unsaturated bond of vanillylamine and having a carbon number of C_8 or less or C_1_2 or more.
(2)バニリルアミンの酸アミドが不飽和結合を含まな
い炭素数C_8以下の酸アミドであることを特徴とする
特許請求の範囲第1項記載のバニリルアミン類含有食品
(2) The vanillylamine-containing food according to claim 1, wherein the acid amide of vanillylamine is an acid amide containing no unsaturated bonds and having a carbon number of C_8 or less.
(3)バニリルアミンの酸アミドが不飽和結合を含まな
い炭素数C_9〜_1_1の酸アミドであることを特徴
とする特許請求の範囲第1項記載のバニリルアミン類含
有食品。
(3) The vanillylamine-containing food according to claim 1, wherein the acid amide of vanillylamine is an acid amide containing no unsaturated bonds and having a carbon number of C_9 to_1_1.
(4)バニリルアミンの酸アミドが不飽和結合を含まな
い炭素数C_1_2以上の酸アミドであることを特徴と
する特許請求の範囲第1項記載のバニリルアミン類含有
食品。
(4) The vanillylamine-containing food according to claim 1, wherein the acid amide of vanillylamine is an acid amide containing no unsaturated bond and having a carbon number of C_1_2 or more.
(5)食品が油脂又は油脂含有食品であることを特徴と
する特許請求の範囲第1項記載のバニリルアミン類含有
食品。
(5) The vanillylamine-containing food according to claim 1, wherein the food is an oil or fat-containing food.
(6)食品が油脂を含有しないことを特徴とする特許請
求の範囲第1項記載のバニリルアミン類含有食品。
(6) The vanillylamine-containing food according to claim 1, characterized in that the food does not contain oil or fat.
(7)食品が、油脂を含有しない調味料、ミートテンダ
ライザー、飲料であることを特徴とする特許請求の範囲
第6項記載のバニリルアミン類含有食品。
(7) The vanillylamine-containing food according to claim 6, wherein the food is a seasoning, a meat tenderizer, or a beverage that does not contain fat or oil.
JP59281691A 1984-06-11 1984-12-26 Food containing vanilylamine Pending JPS61152260A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59281691A JPS61152260A (en) 1984-12-26 1984-12-26 Food containing vanilylamine
DE19853520761 DE3520761A1 (en) 1984-06-11 1985-06-10 USE OF VANILLYLAMINE OR VANILLYLAMIDES TO PROMOTE FAT METABOLISM
US06/834,102 US4680313A (en) 1984-06-11 1986-02-24 Acceleration of lipid metabolism using vanillylamine derivatives
US07/002,942 US4789687A (en) 1984-06-11 1987-01-13 Food containing vanillylamine and derivatives useful for accellerating lipid metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59281691A JPS61152260A (en) 1984-12-26 1984-12-26 Food containing vanilylamine

Publications (1)

Publication Number Publication Date
JPS61152260A true JPS61152260A (en) 1986-07-10

Family

ID=17642635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59281691A Pending JPS61152260A (en) 1984-06-11 1984-12-26 Food containing vanilylamine

Country Status (1)

Country Link
JP (1) JPS61152260A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151674A (en) * 1999-11-24 2001-06-05 Maruzen Pharmaceut Co Ltd Caries-preventing agent, agent for oral cavity application and food and drink

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53132534A (en) * 1977-04-26 1978-11-18 Eisai Co Ltd Vanillylacylamide and antioxidant containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53132534A (en) * 1977-04-26 1978-11-18 Eisai Co Ltd Vanillylacylamide and antioxidant containing the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151674A (en) * 1999-11-24 2001-06-05 Maruzen Pharmaceut Co Ltd Caries-preventing agent, agent for oral cavity application and food and drink
JP4623791B2 (en) * 1999-11-24 2011-02-02 丸善製薬株式会社 Caries inhibitor, oral preparation and food and drink

Similar Documents

Publication Publication Date Title
RU2214107C2 (en) Canned meat for infant food
RU2294117C2 (en) Shaped fish semi-finished product for preschool and school infant nutrition
JP5112865B2 (en) Composition for preventing or treating hemoglobinuria or myoglobinuria
WO2011096413A1 (en) Agent for improving motility function
US4789687A (en) Food containing vanillylamine and derivatives useful for accellerating lipid metabolism
JP2013227228A (en) Muscle increasing agent
JP2009286703A (en) Body fat accumulation-improving agent and metabolic syndrome-improving agent containing d-tagatose as active ingredient
RU2524076C1 (en) Mayonnaise-type sauce with &#34;bud zdorov&#34; flax meal
JP6252922B2 (en) Testosterone secretion promoter, anti-fatigue agent, and production method and use thereof
EP3345595B1 (en) Composition for muscle building and method for building muscle
JPS61152260A (en) Food containing vanilylamine
JP2007238581A (en) Composition for ameliorating arthritis
Amani et al. Processed meat products: health issues and attempts toward healthier food
JP2017523183A5 (en)
RU2279819C1 (en) Dietetic minced meat semi-finished products
JP6024942B2 (en) Testosterone secretion promoter, anti-fatigue agent, and production method and use thereof
US20040265426A1 (en) Process for producing miso
WO2020013721A2 (en) Food preparation based on horseradish and procedure for obtaining it
JPH0458303B2 (en)
JPS60262551A (en) Fat or oil and food containing fat or oil
WO2007132714A1 (en) Agent for increasing bone density
CN111615338A (en) Stabilization of omega-3 fatty acids with bran
KR20010066988A (en) The composites of raw-type tea containing octacosanol
CN113491334B (en) nutritional composition
WO2023218868A1 (en) Sympathetic nerve activator and composition for sympathetic nerve activation